Bangrui Biotech Q4 2025 Financial Report
Bangrui Biotech Co., Ltd. reported a basic EPS of NT$ 4.13 for Q4 2025. The company achieved operating revenue of NT$ 306 million and a net income after tax of NT$ 103 million.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:21 (16h 21m after Collected)
Company Code: 6955, Company Name: Bangrui Biotech Co., Ltd., Industry: Biotechnology and Medical Industry, Year/Quarter: 2025 Q4, Basic Earnings Per Share: NT$ 4.13, Operating Revenue: NT$ 306 million, Net Income After Tax: NT$ 103 million